Indirect recognition of donor HLA-DR peptides in organ allograft rejection

Journal of Clinical Investigation

Volumn 98, Issue 5, 1996, Pages 1150-1157

  Liu, Zhuoru ^a   Colovai, Adriana I ^a   Tugulea, Sorina ^a   Reed, Elaine F ^a   Fisher, Peter E ^a   Mancini, Donna ^a   Rose, Eric A ^a   Cortesini, Raffaello ^b   Michler, Robert E ^a   Suciu Foca, Nicole ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

acute rejection; allopeptide; alloreactivity; MHC restriction; T cell determinants

Indexed keywords

HLA DR ANTIGEN;

ALLOIMMUNITY; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 9544241307     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118898     Document Type: Article

References (44)

1. Steinman, RM., and M.D. Witmer. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Immunol. 75:5132-5136.
2. Mason, D.W., C.W. Pugh, and M. Webb. 1981. The rat mixed lymphocyte reaction: roles of a dendritic cell in intestinal lymph and T-cell subsets defined by monoclonal antibodies. Immunol. 44:75-87.
3. Lechler, R.I., and J.R. Batchelor. 1982. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155:31-41.
4. Matzinger, P. and M.J. Bevan. 1977. Hypothesis: Why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol. 29: 1-5.
5. Lechler, R.I., G. Lombardi, J.R. Batchelor, N. Reinsmoen, and F.H. Bach. 1990. The molecular basis of alloreactivity. Immunol. Today. 11:83-88.
6. Lechler, R.I., T. Heaton, L. Barber, V. Ball, J.R. Batchelor, and G. Lombardi. 1992. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol. Lett. 34:63-70.
7. Lo, D., L.C. Burkly, R.A. Flavell, R.D. Palmiter, and Brinster, R.L. 1989. Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J. Exp. Med. 170:87-104.
8. Gaspari, A.A., M.K. Jenkins, and S.I. Katz. 1988. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific TH1 clones. J. Immunol. 7:2216-2222.
9. Bradley, J.A. 1996. Indirect T cell recognition in allograft rejection. Int. Rev. Immunol. 13:245-255.
10. Benichou, G., and E.V. Fedoseyeva. 1996. The contribution of peptides to T cell allorecognition and allograft rejection. Int Rev. Immunol. 13:231-243.
11. Benichou, G., A.P. Takizawa, A.C. Olson, M. McMillan, and E.E. Sercarz. 1992. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175: 305-308.
12. Watschinger, B., L. Gallon, C.B. Carpenter, and M.H. Seyegh. 1994. Mechanisms of allo-recognition: Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen- presenting cells. Transplantation. 57:572-576.
13. Sayegh, M.H., and C.B. Carpenter. 1996. Role of indirect allorecognition in allograft rejection. Int Rev. Immunol. 13:221-229.
14. Dalchau, R., J. Fangmann, and J.W. Fabre. 1992. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation. Eur. J. Immunol. 22:669-677.
15. Fangmann, J., R. Dalchau, and J.W. Fabre. 1992. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 75:1521-1529.
16. Sayegh, M.H., S.J. Khoury, W.W. Hancock, H.L. Weiner, and C.B. Carpenter. 1992. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc. Natl. Acad. Sci. USA. 89:7762-7766.
17. Auchincloss, H. Jr., R. Lee, S. Shea, J.S. Markowitz, M.J. Grusby, and L.H. Glimcher. 1993. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA. 90:3373-3377.
18. Lee, R.S., M.J. Grusby, L.H. Glimcher, H.J. Winn, and H. Auchincloss, Jr. 1994. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 197:865-872.
19. Parker, D.C. 1993. T cell dependent B cell activation. Ann. Rev. Immunol. 11:331-360.
20. Liu, Z., Y.K. Sun, Y.P. Xi, A. Maffei, E. Reed, P.E. Harris and N. Suciu-Foca. 1993. Contribution of direct and indirect recognition pathway to T cell alloreactivity. J. Exp. Med. 177:1643-1650.
21. Liu, Z., N. Braunstein, and N. Suciu-Foca. 1992. T cell recognition of allo-peptides in context of syngeneic MHC. J. Immunol. 148:35-40.
22. Liu, Z., P. Harris, A. I. Colovai, E.F. Reed, A. Maffei, and N. Suciu-Foca. 1995. Suppression of the indirect pathway of T cell reactivity by high doses of allopeptide. Autoimmunity. 21:173-184.
23. Liu, Z., P. Harris, A.I. Culovai, E.F. Reed, A. Maffei, and N. Suciu-Foca. 1996. Indirect recognition of donor MHC-class II antigens in human transplantation. Clin. Immunol. and Immunopathol. Vol. 78. In press.
24. Colovai, A.I., E. Renna-Molajoni, R. Cortesini, and N. Suciu-Foca. 1996. New approaches to specific immunomodulation in transplantation. Int. Rev. Immunol. 13:161-172.
25. Benichou, G., E. Fedoseyeva, P.V. Lehmann, C.A. Olson, H.M. Geysen, M. McMillian, and E.E. Sercarz. 1994. Limited T cell response to donor MHC peptides during allograft rejection. J. Immunol. 153:938-941.
26. Liu, Z., Y.K. Sun, Y.P. Xi, B. Hong, P.E. Harris, E.F. Reed, and N. Suciu-Foca. 1993. Limited usage of TCR Vβ genes by allopeptide specific T cells. J. Immunol. 150:3180-3186.
27. Fisher, P.E., N. Suciu-Foca, E. Ho, R.E. Michler, E.A. Rose, and M. Mancini. 1995. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy. J. Heart & Lung Transplant. 14:1156-1161.
28. Billingham, M.D. 1995. Pathology of human cardiac transplantation. In: Cardiovascular pathology. Clincopathologic correlations and pathogenetic mechanisms. F.S. Schoen and M.A. Gimbrone, Jr., editors. Williams and Wilkins, Baltimore, MD. 108-129.
29. Bodmer, J.G., S. G. E. Marsh, E.D. Albert, W. F. Bodmer, B. Dupont, H.A. Erlich, B. Mach, W.R. Mayr, P. Parham, T. Sasazuki, G.M. Schreuder, J.L. Strominger, A. Svejgaard, and P.I. Terasaki. 1994. Nomenclature for factors of the HLA system. Human Immunol. 41:1-20.
30. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H.L. Weiner, and D.A. Hader. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973-984.
31. Dixon, W.J., M.B. Brown, L. Engelman, R.I. Jennrich. 1990. BMDP statistical software manual to accompany the 1990 software release. Berkeley University of California Press.
32. Sawyer, G.J., R. Dalchau, and J.W. Fabre. 1993. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transplant. Immunol. 1:77-81.
33. Gallon, L., B. Watschinger, B. Murphy, E. Akalin, M.H. Sayegh, and C.B. Carpenter. 1995. The indirect pathway of allorecognition. In The Occurrence of Self-restricted T Cell Recognition of Allo-MHC Peptides Early in Acute Renal Allograft Rejection and Its Inhibition by Conventional Immunosuppression. Transplantation. 59:612-616.
34. Barbey, C. C. Watts, and G. Corradin. 1995. Antigen-processing organelles from DRβ1*1101 and DRβ1*1104 B cell lines display a differential degradation activity. Eur. J. Immunol. 25:311-36.
35. Fling, S., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II peptide complex formation in antigen-presenting cells. Nature (Lond.). 368:554-558.
36. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature (Lond.). 368: 551-553.
37. Braun, Y.M., A. McCormack, G. Webb, and J.R. Batchelor. 1993. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation. 55:117-182.
38. Vidard, L., K.R. Rock, and B. Benacerraf. 1992. Heterogeneity in antigen processing of different types of antigen presenting cells. J. Immunol. 149: 1905-1911.
39. LaSalle, J.M., P.J. Tolentino, G.J. Freeman, L.M. Nadler, and D.A. Hafler. 1992. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J. Exp. Med. 176:177-186.
40. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (Lond.). 346:183-187.
41. Liu, Z., Y.K. Sun, Y.P. Xi, P. Harris, and N. Suciu-Foca. 1992. T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules. J. Exp. Med. 175:1663-1668.
42. + T cells is governed by a processing factor that maps to the class II region of the major histocompaibility complex locus. J. Exp. Med. 182:1481-1491.
43. McRae, B.L. C.L. Vanderlugt, M.C. Cal Canto, and S.D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
44. Suciu-Foca, N., E. Reed, V.D. D'Agati, E. Ho, D.J. Cohen, A.I. Benvenisty, R. McCabe, J.M. Brensilver, D.W. King, and M.A. Hardy. 1991. Soluble HLA antigens, anti-HLA antibodies and anti-idiotypic antibodies in the circulation of renal transplant recipients. Transplantation. 51:593-601.